Innovative Medicine

Innovative Medicine

April 28, 2011

ZYTIGA™ (Abiraterone Acetate) Receives FDA Approval For Treatment Of Metastatic Prostate Cancer After Priority Review

First Once-Daily, Oral Treatment for Metastatic Prostate Cancer Inhibits Androgen Production at All Three Sources

Innovative Medicine

August 31, 2010

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

Latest Results from EINSTEIN Program Presented at European Society of Cardiology Congress

Innovative Medicine

December 1, 2009

New Drug Application Submitted To FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain

Innovative Medicine

June 17, 2009

Unique Collaboration between TB Alliance and Tibotec to Accelerate Tuberculosis Drug Development

Innovative Medicine

May 9, 2008

New Study Suggests Tapentadol IR For Acute Pain is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR

Innovative Medicine

May 9, 2008

Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile

Innovative Medicine

May 9, 2008

New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective For Acute Pain From Common Foot Surgery

Novel Pain Medicine Studied in Patients Following Bunionectomy